Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Bouk CH"'
Autor:
De Abreu FB; Dartmouth-Hitchcock Medical Center and Norris Cotton Cancer Center, Lebanon, NH, and the Geisel School of Medicine, Hanover, NH., Peterson JD; Dartmouth-Hitchcock Medical Center and Norris Cotton Cancer Center, Lebanon, NH, and the Geisel School of Medicine, Hanover, NH., Deharvengt SJ; Dartmouth-Hitchcock Medical Center and Norris Cotton Cancer Center, Lebanon, NH, and the Geisel School of Medicine, Hanover, NH., Daber R; BioReference Laboratories, Elmwood Park, NJ., Sarsani VK; The Jackson Laboratory for Genomic Medicine, Farmington, CT., Spotlow V; The Jackson Laboratory for Genomic Medicine, Farmington, CT., Harrington RD; Molecular Characterization and Clinical Assay Development Laboratory, Leidos Biomedical Research Inc., and Frederick National Laboratory for Cancer Research, Frederick, MD., Lih CJ; Molecular Characterization and Clinical Assay Development Laboratory, Leidos Biomedical Research Inc., and Frederick National Laboratory for Cancer Research, Frederick, MD., Williams PM; Molecular Characterization and Clinical Assay Development Laboratory, Leidos Biomedical Research Inc., and Frederick National Laboratory for Cancer Research, Frederick, MD., Bouk CH; Molecular Characterization and Clinical Assay Development Laboratory, Leidos Biomedical Research Inc., and Frederick National Laboratory for Cancer Research, Frederick, MD., Konigshofer Y; Seracare Life Sciences, Gaithersburg, MD., Huang C; Seracare Life Sciences, Gaithersburg, MD., Anekella B; Seracare Life Sciences, Gaithersburg, MD., Davis L; Seracare Life Sciences, Gaithersburg, MD., Garlick RK; Seracare Life Sciences, Gaithersburg, MD., Ferreira-Gonzalez A; Virginia Commonwealth University, Richmond, VA., Dumur CI; Virginia Commonwealth University, Richmond, VA., Fernandes H; Weill Cornell Medical Center, New York City, NY; and., Haralampu S; Beta-Innovations, Belmont, MA., Tsongalis GJ; Dartmouth-Hitchcock Medical Center and Norris Cotton Cancer Center, Lebanon, NH, and the Geisel School of Medicine, Hanover, NH.
Publikováno v:
The journal of applied laboratory medicine [J Appl Lab Med] 2017 Sep 01; Vol. 2 (2), pp. 138-149.
Autor:
Lih CJ; Molecular Characterization and Clinical Assay Development Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Harrington RD; Molecular Characterization and Clinical Assay Development Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Sims DJ; Molecular Characterization and Clinical Assay Development Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Harper KN; Molecular Characterization and Clinical Assay Development Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Bouk CH; Molecular Characterization and Clinical Assay Development Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Datta V; Molecular Characterization and Clinical Assay Development Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Yau J; Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Singh RR; Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Routbort MJ; Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Luthra R; Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Patel KP; Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Mantha GS; Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Krishnamurthy S; Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Ronski K; Department of Pathology, School of Medicine, Yale University, New Haven, Connecticut., Walther Z; Department of Pathology, School of Medicine, Yale University, New Haven, Connecticut., Finberg KE; Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Canosa S; Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Robinson H; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts., Raymond A; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts., Le LP; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts., McShane LM; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Polley EC; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Conley BA; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Doroshow JH; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Iafrate AJ; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts., Sklar JL; Department of Pathology, School of Medicine, Yale University, New Haven, Connecticut., Hamilton SR; Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Williams PM; Molecular Characterization and Clinical Assay Development Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland. Electronic address: mickey.williams@nih.gov.
Publikováno v:
The Journal of molecular diagnostics : JMD [J Mol Diagn] 2017 Mar; Vol. 19 (2), pp. 313-327. Date of Electronic Publication: 2017 Feb 07.
Autor:
Sims DJ; Molecular Characterization and Clinical Assay Development Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Harrington RD; Molecular Characterization and Clinical Assay Development Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Polley EC; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Forbes TD; Molecular Characterization and Clinical Assay Development Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Mehaffey MG; Molecular Characterization and Clinical Assay Development Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland., McGregor PM 3rd; Molecular Characterization and Clinical Assay Development Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Camalier CE; Molecular Characterization and Clinical Assay Development Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Harper KN; Molecular Characterization and Clinical Assay Development Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Bouk CH; Molecular Characterization and Clinical Assay Development Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Das B; Molecular Characterization and Clinical Assay Development Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Conley BA; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Doroshow JH; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Williams PM; Molecular Characterization and Clinical Assay Development Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Lih CJ; Molecular Characterization and Clinical Assay Development Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland. Electronic address: jason.lih@nih.gov.
Publikováno v:
The Journal of molecular diagnostics : JMD [J Mol Diagn] 2016 May; Vol. 18 (3), pp. 336-349.
Autor:
Lih CJ; Molecular Characterization and Clinical Assay Development Laboratory, Leidos Biomedical Research Inc., and Frederick National Laboratory for Cancer Research, Frederick, Maryland. Electronic address: jason.lih@nih.gov., Sims DJ; Molecular Characterization and Clinical Assay Development Laboratory, Leidos Biomedical Research Inc., and Frederick National Laboratory for Cancer Research, Frederick, Maryland., Harrington RD; Molecular Characterization and Clinical Assay Development Laboratory, Leidos Biomedical Research Inc., and Frederick National Laboratory for Cancer Research, Frederick, Maryland., Polley EC; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Zhao Y; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Mehaffey MG; Molecular Characterization and Clinical Assay Development Laboratory, Leidos Biomedical Research Inc., and Frederick National Laboratory for Cancer Research, Frederick, Maryland., Forbes TD; Molecular Characterization and Clinical Assay Development Laboratory, Leidos Biomedical Research Inc., and Frederick National Laboratory for Cancer Research, Frederick, Maryland., Das B; Molecular Characterization and Clinical Assay Development Laboratory, Leidos Biomedical Research Inc., and Frederick National Laboratory for Cancer Research, Frederick, Maryland., Walsh WD; Molecular Characterization and Clinical Assay Development Laboratory, Leidos Biomedical Research Inc., and Frederick National Laboratory for Cancer Research, Frederick, Maryland., Datta V; Molecular Characterization and Clinical Assay Development Laboratory, Leidos Biomedical Research Inc., and Frederick National Laboratory for Cancer Research, Frederick, Maryland., Harper KN; Molecular Characterization and Clinical Assay Development Laboratory, Leidos Biomedical Research Inc., and Frederick National Laboratory for Cancer Research, Frederick, Maryland., Bouk CH; Molecular Characterization and Clinical Assay Development Laboratory, Leidos Biomedical Research Inc., and Frederick National Laboratory for Cancer Research, Frederick, Maryland., Rubinstein LV; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Simon RM; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Conley BA; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Chen AP; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Kummar S; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Doroshow JH; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Williams PM; Molecular Characterization and Clinical Assay Development Laboratory, Leidos Biomedical Research Inc., and Frederick National Laboratory for Cancer Research, Frederick, Maryland; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland.
Publikováno v:
The Journal of molecular diagnostics : JMD [J Mol Diagn] 2016 Jan; Vol. 18 (1), pp. 51-67. Date of Electronic Publication: 2015 Nov 18.